Farms.com Home   News

Pulse Market Insight #232

Weather is and always will be the dominant driver of crop markets. That’s obvious. All other factors – geopolitics, trade wars, government policy, hedge funds – take a back seat to rainfall and temperatures. This time of year is the most critical, as crops emerge and yield potential is already being determined.

While every growing season is different, western Canada has seen extremes in the past 3-4 years. In some areas, 2020 was already a drought year, which then widened and deepened in 2021. Most, but not all, areas saw relief in 2022. The 2023 growing season started with widespread concerns about dryness, especially in central and northern areas that are typically wetter at the beginning of the year. Just in the past week though, welcome rains fell in northwest Alberta and north central Saskatchewan. But that still leaves large parts of Alberta facing dry conditions as the crop emerges.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.